The Veeda Newsletter

Clinical Research

6 Diabetes Research Studies to Watch in 2019

As medical technology and research continues to make advancements, each New Year brings about fresh developments and new opportunities for diabetes management.
Read more : :

Immune profiling: A new opportunity for drug development

“The immune system is a sensory organ as much as it is an organ that’s protecting us,” notes John Wherry, chair of pharmacology, in a video marking the opening of the new Allen Institute for Immunology, a research organization for advancing the fundamental understanding of human immunology.
Read more :

FDA Releases Final Guidance on Immunogenicity Testing for Biologics and Biosimilars

The FDA recently released final guidance about the use of therapeutic proteins in developing biologics and biosimilars. "Immunogenicity Testing of Therapeutic Protein Products-developing and Validating Assays for Anti-Drug Antibody Detection" represents current FDA thinking about developing and validating assays for anti-drug antibody (ADA) detection.
Read more :

New insight into cell receptors opens the way for tailored cancer drugs

New research on how cancer mutations influence a certain type of receptor on the cell membrane opens the way for the development of tailored drugs for certain cancers, such as rectal cancer and lung cancer.
Read more :

The Rise of Orphan Drugs: A New Paradigm for the Future

A number of regulatory incentives have stimulated a growing investment in orphan drug development by the biotech and pharmaceutical industry," says Dr. Terence Eagleton, Senior Medical Director at Medpace.
Read more :
Contact Us